Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Israel Medical Association Journal : IMAJ
|
July 12, 2021
Multiple Myeloma with Systemic Amyloidosis: Serum Free Light Chain Dimerization Analysis in the Diagnosis of an Equivocal Case of Plasma Cell Dyscrasia
Adrian Duek, Batia Kaplan, Yafit Segman, et al.
Harefuah
|
March 14, 2023
[PROLONGED POST-COVID-19 ANEMIA]
Yafit Segman, Adrian Duek, Yair Goldhechet, et al.
The Israel Medical Association Journal : IMAJ
|
October 30, 2022
Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit
Adrian Duek, Emmanuel Lellouche, Sharon Ben Baruch, et al.
Journal of Medical Screening
|
July 12, 2022
Lymphoproliferative disease detected by breast cancer screening
Efrat Luttwak, Yafit Segman, May Saban, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 7, 2023
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
Tal Brosh-Nissimov, Nir Ma'aravi, Daniel Leshin-Carmel, et al.
The American Journal of Cardiology
|
February 24, 2016
Comparison of Triggering and Nontriggering Factors in ST-Segment Elevation Myocardial Infarction and Extent of Coronary Arterial Narrowing
Jeremy Ben-Shoshan, Yafit Segman-Rosenstveig, Yaron Arbel, et al.
Leukemia & Lymphoma
|
September 28, 2020
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience
Yafit Segman, Elena Ribakovsky, Abraham Avigdor, et al.
Annals of Hematology
|
January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis
Irit Avivi, Chava Perry, Yafit Segman, et al.
Cancer Medicine
|
February 24, 2024
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab
Tali Shafat, Daniel Grupel, Tzvika Porges, et al.
Infectious Diseases and Therapy
|
December 9, 2024
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
Hovav Azuly, Tali Shafat, Daniel Grupel, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Israel Medical Association Journal : IMAJ
|
July 12, 2021
Multiple Myeloma with Systemic Amyloidosis: Serum Free Light Chain Dimerization Analysis in the Diagnosis of an Equivocal Case of Plasma Cell Dyscrasia
Adrian Duek, Batia Kaplan, Yafit Segman, et al.
Harefuah
|
March 14, 2023
[PROLONGED POST-COVID-19 ANEMIA]
Yafit Segman, Adrian Duek, Yair Goldhechet, et al.
The Israel Medical Association Journal : IMAJ
|
October 30, 2022
Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit
Adrian Duek, Emmanuel Lellouche, Sharon Ben Baruch, et al.
Journal of Medical Screening
|
July 12, 2022
Lymphoproliferative disease detected by breast cancer screening
Efrat Luttwak, Yafit Segman, May Saban, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 7, 2023
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
Tal Brosh-Nissimov, Nir Ma'aravi, Daniel Leshin-Carmel, et al.
The American Journal of Cardiology
|
February 24, 2016
Comparison of Triggering and Nontriggering Factors in ST-Segment Elevation Myocardial Infarction and Extent of Coronary Arterial Narrowing
Jeremy Ben-Shoshan, Yafit Segman-Rosenstveig, Yaron Arbel, et al.
Leukemia & Lymphoma
|
September 28, 2020
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience
Yafit Segman, Elena Ribakovsky, Abraham Avigdor, et al.
Annals of Hematology
|
January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis
Irit Avivi, Chava Perry, Yafit Segman, et al.
Cancer Medicine
|
February 24, 2024
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab
Tali Shafat, Daniel Grupel, Tzvika Porges, et al.
Infectious Diseases and Therapy
|
December 9, 2024
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
Hovav Azuly, Tali Shafat, Daniel Grupel, et al.
Page
of 1